Purple Biotech (PPBT) Current Deferred Revenue (2019)
Purple Biotech (PPBT) has disclosed Current Deferred Revenue for 1 consecutive years, with $961000.0 as the latest value for Q4 2019.
- On a quarterly basis, Current Deferred Revenue changed N/A to $961000.0 in Q4 2019 year-over-year; TTM through Dec 2019 was $961000.0, a N/A change, with the full-year FY2019 number at $961000.0, changed N/A from a year prior.
- Current Deferred Revenue was $961000.0 for Q4 2019 at Purple Biotech.
- In the past five years, Current Deferred Revenue ranged from a high of $961000.0 in Q4 2019 to a low of $961000.0 in Q4 2019.